Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Health Priorities | 36 | 2023 | 380 | 7.990 |
Why?
|
Health Care Rationing | 31 | 2022 | 437 | 5.500 |
Why?
|
Health Policy | 23 | 2023 | 2661 | 2.570 |
Why?
|
Quality-Adjusted Life Years | 20 | 2021 | 1683 | 2.480 |
Why?
|
Ethiopia | 26 | 2023 | 495 | 2.440 |
Why?
|
Cost-Benefit Analysis | 39 | 2023 | 5391 | 2.120 |
Why?
|
Health Services | 8 | 2023 | 758 | 2.050 |
Why?
|
Delivery of Health Care | 23 | 2023 | 5319 | 2.030 |
Why?
|
Norway | 33 | 2022 | 448 | 1.960 |
Why?
|
Social Justice | 15 | 2021 | 456 | 1.780 |
Why?
|
Decision Making | 22 | 2022 | 3887 | 1.660 |
Why?
|
Health Expenditures | 13 | 2023 | 2348 | 1.570 |
Why?
|
Morals | 5 | 2021 | 284 | 1.570 |
Why?
|
Health Services Accessibility | 23 | 2021 | 5137 | 1.430 |
Why?
|
Life Expectancy | 11 | 2022 | 1184 | 1.340 |
Why?
|
Communicable Diseases | 6 | 2023 | 880 | 1.310 |
Why?
|
Social Values | 9 | 2012 | 224 | 1.260 |
Why?
|
Health Facilities | 3 | 2023 | 573 | 1.230 |
Why?
|
Poverty | 17 | 2023 | 2660 | 1.210 |
Why?
|
Neglected Diseases | 2 | 2021 | 64 | 1.180 |
Why?
|
Health Status Disparities | 11 | 2023 | 1797 | 1.160 |
Why?
|
Maternal Mortality | 5 | 2015 | 310 | 1.130 |
Why?
|
Developing Countries | 14 | 2023 | 2815 | 1.110 |
Why?
|
Healthcare Disparities | 11 | 2021 | 3158 | 1.110 |
Why?
|
Child Mortality | 4 | 2015 | 198 | 1.060 |
Why?
|
Health Care Reform | 5 | 2023 | 1261 | 1.030 |
Why?
|
Ethics, Medical | 9 | 2021 | 792 | 1.020 |
Why?
|
Health Planning | 3 | 2021 | 238 | 1.000 |
Why?
|
Physicians, Family | 4 | 2008 | 345 | 0.980 |
Why?
|
Resource Allocation | 12 | 2020 | 341 | 0.970 |
Why?
|
Policy Making | 6 | 2020 | 554 | 0.960 |
Why?
|
Nutrition Disorders | 2 | 2015 | 211 | 0.950 |
Why?
|
Technology Assessment, Biomedical | 4 | 2023 | 306 | 0.900 |
Why?
|
Tropical Medicine | 2 | 2021 | 49 | 0.870 |
Why?
|
Infant Mortality | 5 | 2017 | 754 | 0.840 |
Why?
|
Tanzania | 16 | 2017 | 1346 | 0.840 |
Why?
|
Choice Behavior | 6 | 2018 | 803 | 0.840 |
Why?
|
Patient Rights | 4 | 2018 | 126 | 0.830 |
Why?
|
Carbon Footprint | 1 | 2021 | 15 | 0.820 |
Why?
|
Goals | 5 | 2018 | 706 | 0.810 |
Why?
|
Models, Theoretical | 6 | 2022 | 3589 | 0.780 |
Why?
|
Public Health | 8 | 2022 | 2603 | 0.760 |
Why?
|
Drug Costs | 3 | 2022 | 1105 | 0.740 |
Why?
|
Immunity, Herd | 1 | 2020 | 44 | 0.720 |
Why?
|
Communicable Disease Control | 3 | 2021 | 857 | 0.720 |
Why?
|
Euthanasia, Passive | 3 | 2010 | 66 | 0.710 |
Why?
|
Humans | 184 | 2023 | 744343 | 0.700 |
Why?
|
Contraceptive Agents | 1 | 2021 | 151 | 0.700 |
Why?
|
Biodiversity | 1 | 2022 | 341 | 0.700 |
Why?
|
Human Rights | 4 | 2018 | 307 | 0.690 |
Why?
|
Carbon | 1 | 2023 | 687 | 0.690 |
Why?
|
Bicycling | 1 | 2020 | 176 | 0.680 |
Why?
|
Patient Selection | 8 | 2010 | 4215 | 0.670 |
Why?
|
Social Responsibility | 6 | 2023 | 389 | 0.670 |
Why?
|
Disabled Persons | 4 | 2017 | 1212 | 0.660 |
Why?
|
Financing, Government | 2 | 2021 | 468 | 0.660 |
Why?
|
Epidemics | 3 | 2021 | 523 | 0.630 |
Why?
|
Intensive Care Units, Neonatal | 3 | 2010 | 780 | 0.620 |
Why?
|
Health Care Costs | 9 | 2023 | 3209 | 0.620 |
Why?
|
Health Status | 4 | 2020 | 4034 | 0.610 |
Why?
|
Contraception | 1 | 2021 | 359 | 0.600 |
Why?
|
Evidence-Based Medicine | 10 | 2017 | 3610 | 0.600 |
Why?
|
Life Support Care | 2 | 2010 | 228 | 0.590 |
Why?
|
Pandemics | 8 | 2021 | 8388 | 0.580 |
Why?
|
Waiting Lists | 2 | 2016 | 692 | 0.570 |
Why?
|
Cost of Illness | 5 | 2022 | 1859 | 0.560 |
Why?
|
Health Resources | 6 | 2019 | 911 | 0.540 |
Why?
|
Health Services Administration | 1 | 2016 | 64 | 0.530 |
Why?
|
Ethical Analysis | 6 | 2018 | 42 | 0.530 |
Why?
|
Attitude of Health Personnel | 5 | 2008 | 3843 | 0.530 |
Why?
|
Judicial Role | 1 | 2014 | 37 | 0.510 |
Why?
|
Social Welfare | 2 | 2012 | 87 | 0.500 |
Why?
|
Preventive Medicine | 1 | 2016 | 264 | 0.490 |
Why?
|
Insurance, Health | 5 | 2016 | 2494 | 0.490 |
Why?
|
Prenatal Diagnosis | 1 | 2021 | 1236 | 0.490 |
Why?
|
World Health Organization | 7 | 2023 | 1318 | 0.480 |
Why?
|
Socioeconomic Factors | 17 | 2022 | 7785 | 0.480 |
Why?
|
Tropical Climate | 1 | 2013 | 37 | 0.460 |
Why?
|
Population Groups | 2 | 2018 | 209 | 0.460 |
Why?
|
Maternal Health Services | 4 | 2019 | 455 | 0.460 |
Why?
|
Physician's Role | 5 | 2015 | 943 | 0.450 |
Why?
|
Preventive Health Services | 1 | 2018 | 575 | 0.450 |
Why?
|
Maternal-Child Health Centers | 1 | 2012 | 40 | 0.440 |
Why?
|
Thiazides | 1 | 2012 | 18 | 0.440 |
Why?
|
Legislation, Drug | 1 | 2014 | 206 | 0.430 |
Why?
|
Practice Guidelines as Topic | 9 | 2018 | 7279 | 0.430 |
Why?
|
Physicians | 5 | 2021 | 4567 | 0.420 |
Why?
|
Catastrophic Illness | 2 | 2023 | 57 | 0.410 |
Why?
|
Ethics, Institutional | 1 | 2011 | 37 | 0.410 |
Why?
|
General Practitioners | 1 | 2012 | 103 | 0.390 |
Why?
|
Medical Oncology | 1 | 2023 | 2265 | 0.390 |
Why?
|
Ethics, Clinical | 1 | 2011 | 101 | 0.380 |
Why?
|
Sarcoma | 1 | 2022 | 1897 | 0.380 |
Why?
|
Medical Futility | 2 | 2009 | 127 | 0.380 |
Why?
|
Artemisinins | 3 | 2020 | 221 | 0.380 |
Why?
|
Injections, Intravenous | 1 | 2013 | 1420 | 0.380 |
Why?
|
Infant, Premature | 4 | 2010 | 2044 | 0.380 |
Why?
|
International Cooperation | 6 | 2021 | 1420 | 0.370 |
Why?
|
Randomized Controlled Trials as Topic | 7 | 2018 | 9959 | 0.370 |
Why?
|
State Medicine | 3 | 2021 | 217 | 0.360 |
Why?
|
Anti-Retroviral Agents | 2 | 2011 | 1715 | 0.360 |
Why?
|
National Health Programs | 2 | 2005 | 445 | 0.360 |
Why?
|
Efficiency | 1 | 2013 | 462 | 0.360 |
Why?
|
Health Status Indicators | 4 | 2014 | 969 | 0.350 |
Why?
|
Group Processes | 2 | 2008 | 225 | 0.350 |
Why?
|
Models, Econometric | 2 | 2009 | 218 | 0.350 |
Why?
|
Primary Prevention | 6 | 2016 | 1167 | 0.350 |
Why?
|
Staff Development | 1 | 2011 | 223 | 0.350 |
Why?
|
Antiretroviral Therapy, Highly Active | 3 | 2016 | 1873 | 0.340 |
Why?
|
Models, Economic | 5 | 2020 | 713 | 0.340 |
Why?
|
Cross-Cultural Comparison | 2 | 2010 | 651 | 0.340 |
Why?
|
Mortality | 6 | 2020 | 2864 | 0.340 |
Why?
|
Pediatrics | 2 | 2023 | 3475 | 0.330 |
Why?
|
Alendronate | 2 | 2000 | 171 | 0.330 |
Why?
|
HIV Infections | 9 | 2016 | 16718 | 0.330 |
Why?
|
Antihypertensive Agents | 3 | 2012 | 2046 | 0.320 |
Why?
|
Child Health Services | 3 | 2021 | 667 | 0.320 |
Why?
|
Substance Abuse, Intravenous | 1 | 2013 | 525 | 0.320 |
Why?
|
Reimbursement Mechanisms | 3 | 2017 | 670 | 0.320 |
Why?
|
Medical Staff, Hospital | 1 | 2012 | 603 | 0.310 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3133 | 0.310 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3240 | 0.310 |
Why?
|
Infant, Low Birth Weight | 3 | 2021 | 850 | 0.300 |
Why?
|
Interviews as Topic | 10 | 2012 | 2539 | 0.300 |
Why?
|
Financial Support | 2 | 2018 | 115 | 0.300 |
Why?
|
Health Services Needs and Demand | 4 | 2018 | 1411 | 0.300 |
Why?
|
Climate Change | 2 | 2022 | 418 | 0.290 |
Why?
|
Malaria | 5 | 2020 | 1239 | 0.290 |
Why?
|
Withholding Treatment | 3 | 2008 | 599 | 0.280 |
Why?
|
Neoplasms | 5 | 2023 | 21683 | 0.280 |
Why?
|
Program Development | 1 | 2012 | 1316 | 0.280 |
Why?
|
Health Promotion | 3 | 2017 | 2205 | 0.280 |
Why?
|
Financial Management | 1 | 2007 | 160 | 0.270 |
Why?
|
Infant, Newborn | 17 | 2021 | 25625 | 0.270 |
Why?
|
Patients | 2 | 2008 | 900 | 0.270 |
Why?
|
Parturition | 2 | 2021 | 441 | 0.270 |
Why?
|
Family Practice | 1 | 2008 | 516 | 0.270 |
Why?
|
Health Personnel | 3 | 2022 | 3218 | 0.260 |
Why?
|
Vaccines | 1 | 2014 | 822 | 0.260 |
Why?
|
Female | 58 | 2022 | 380194 | 0.260 |
Why?
|
Delivery, Obstetric | 3 | 2018 | 906 | 0.260 |
Why?
|
Cardiovascular Diseases | 6 | 2017 | 15165 | 0.260 |
Why?
|
Philosophy, Medical | 1 | 2005 | 79 | 0.260 |
Why?
|
Child | 18 | 2023 | 77709 | 0.260 |
Why?
|
Income | 4 | 2021 | 1913 | 0.260 |
Why?
|
Financing, Personal | 2 | 2019 | 308 | 0.260 |
Why?
|
Role | 1 | 2005 | 175 | 0.250 |
Why?
|
Viral Vaccines | 2 | 2021 | 636 | 0.250 |
Why?
|
Resuscitation Orders | 1 | 2007 | 269 | 0.250 |
Why?
|
Pregnancy | 16 | 2021 | 29144 | 0.250 |
Why?
|
Exercise | 1 | 2020 | 5615 | 0.240 |
Why?
|
Gatekeeping | 1 | 2003 | 45 | 0.240 |
Why?
|
Community Health Services | 2 | 2021 | 650 | 0.230 |
Why?
|
Specialization | 3 | 2015 | 777 | 0.230 |
Why?
|
Family Characteristics | 3 | 2023 | 1000 | 0.230 |
Why?
|
Patient Participation | 3 | 2008 | 1457 | 0.230 |
Why?
|
Reoperation | 1 | 2013 | 4201 | 0.230 |
Why?
|
Infant, Premature, Diseases | 1 | 2009 | 706 | 0.230 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 5221 | 0.230 |
Why?
|
Attitude to Death | 1 | 2006 | 382 | 0.220 |
Why?
|
Decision Support Techniques | 4 | 2018 | 1956 | 0.220 |
Why?
|
Value of Life | 1 | 2003 | 97 | 0.220 |
Why?
|
Pharmaceutical Preparations | 3 | 2017 | 1071 | 0.220 |
Why?
|
Diagnostic Tests, Routine | 1 | 2008 | 783 | 0.220 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2013 | 1536 | 0.210 |
Why?
|
Program Evaluation | 1 | 2011 | 2488 | 0.210 |
Why?
|
United Nations | 2 | 2014 | 165 | 0.210 |
Why?
|
Obstetric Labor Complications | 1 | 2004 | 238 | 0.210 |
Why?
|
Budgets | 1 | 2023 | 229 | 0.210 |
Why?
|
Adult | 31 | 2021 | 214055 | 0.200 |
Why?
|
Incidence | 7 | 2023 | 20947 | 0.200 |
Why?
|
Obstetrics | 2 | 2007 | 658 | 0.200 |
Why?
|
Costs and Cost Analysis | 4 | 2021 | 1681 | 0.200 |
Why?
|
Employment | 3 | 2019 | 1132 | 0.200 |
Why?
|
Antineoplastic Agents | 4 | 2022 | 13695 | 0.190 |
Why?
|
Rural Population | 5 | 2021 | 2210 | 0.190 |
Why?
|
Decision Trees | 1 | 2023 | 506 | 0.190 |
Why?
|
Middle Aged | 29 | 2021 | 213383 | 0.190 |
Why?
|
Public Opinion | 2 | 2002 | 477 | 0.190 |
Why?
|
Prenatal Care | 2 | 2018 | 1092 | 0.190 |
Why?
|
Uganda | 7 | 2008 | 1243 | 0.190 |
Why?
|
Health Planning Guidelines | 1 | 2001 | 163 | 0.180 |
Why?
|
Guideline Adherence | 3 | 2018 | 2266 | 0.180 |
Why?
|
Urban Population | 3 | 2013 | 2021 | 0.180 |
Why?
|
India | 4 | 2017 | 2197 | 0.180 |
Why?
|
Quinolines | 2 | 2016 | 732 | 0.180 |
Why?
|
Medical Records Systems, Computerized | 1 | 2006 | 1205 | 0.180 |
Why?
|
Private Sector | 1 | 2023 | 392 | 0.180 |
Why?
|
Insecticide-Treated Bednets | 1 | 2020 | 64 | 0.170 |
Why?
|
Referral and Consultation | 3 | 2008 | 3528 | 0.170 |
Why?
|
Age Factors | 7 | 2020 | 18370 | 0.170 |
Why?
|
Knowledge | 1 | 2001 | 181 | 0.170 |
Why?
|
Cost Sharing | 1 | 2023 | 407 | 0.170 |
Why?
|
Travel | 2 | 2021 | 788 | 0.170 |
Why?
|
Australia | 1 | 2022 | 1170 | 0.170 |
Why?
|
Male | 38 | 2021 | 350118 | 0.170 |
Why?
|
Quality of Life | 6 | 2015 | 12804 | 0.170 |
Why?
|
Focus Groups | 4 | 2012 | 1321 | 0.170 |
Why?
|
Costa Rica | 2 | 2018 | 177 | 0.170 |
Why?
|
Medicine | 2 | 2005 | 946 | 0.160 |
Why?
|
Altruism | 1 | 2020 | 204 | 0.160 |
Why?
|
Child, Preschool | 12 | 2021 | 41006 | 0.160 |
Why?
|
Malaria Vaccines | 1 | 2020 | 158 | 0.160 |
Why?
|
Physician-Patient Relations | 4 | 2008 | 3229 | 0.160 |
Why?
|
Young Adult | 14 | 2021 | 56430 | 0.160 |
Why?
|
Eligibility Determination | 1 | 2002 | 403 | 0.160 |
Why?
|
HELLP Syndrome | 1 | 2018 | 41 | 0.160 |
Why?
|
Hypertension | 4 | 2014 | 8480 | 0.160 |
Why?
|
Quality of Health Care | 3 | 2018 | 4371 | 0.160 |
Why?
|
Cities | 1 | 2020 | 513 | 0.160 |
Why?
|
Family Planning Services | 1 | 2021 | 263 | 0.160 |
Why?
|
Terminal Care | 1 | 2010 | 1694 | 0.160 |
Why?
|
Fractures, Spontaneous | 1 | 2000 | 230 | 0.160 |
Why?
|
Antimalarials | 2 | 2016 | 905 | 0.160 |
Why?
|
Gestational Age | 4 | 2018 | 3493 | 0.160 |
Why?
|
Insecticides | 1 | 2020 | 195 | 0.160 |
Why?
|
Coronavirus | 1 | 2021 | 158 | 0.160 |
Why?
|
Eclampsia | 1 | 2018 | 58 | 0.160 |
Why?
|
Adolescent | 14 | 2023 | 85781 | 0.150 |
Why?
|
Ethanolamines | 2 | 2016 | 158 | 0.150 |
Why?
|
Insurance Claim Review | 1 | 2002 | 720 | 0.150 |
Why?
|
Drugs, Essential | 1 | 2018 | 73 | 0.150 |
Why?
|
Infant | 12 | 2021 | 35136 | 0.150 |
Why?
|
Lung Neoplasms | 1 | 2022 | 13102 | 0.150 |
Why?
|
Patients' Rooms | 1 | 2017 | 63 | 0.150 |
Why?
|
Drug Industry | 2 | 2021 | 746 | 0.150 |
Why?
|
Perinatal Care | 1 | 2019 | 227 | 0.150 |
Why?
|
Osteoporosis, Postmenopausal | 1 | 2000 | 386 | 0.150 |
Why?
|
Fluorenes | 2 | 2016 | 160 | 0.140 |
Why?
|
Perinatal Mortality | 1 | 2017 | 105 | 0.140 |
Why?
|
CD4 Lymphocyte Count | 2 | 2016 | 2559 | 0.140 |
Why?
|
Anti-HIV Agents | 2 | 2011 | 4256 | 0.140 |
Why?
|
Qualitative Research | 4 | 2011 | 2682 | 0.140 |
Why?
|
Aged | 17 | 2021 | 163280 | 0.140 |
Why?
|
Cross-Sectional Studies | 6 | 2022 | 25043 | 0.140 |
Why?
|
Disease | 1 | 2002 | 680 | 0.140 |
Why?
|
Models, Statistical | 6 | 2018 | 5102 | 0.140 |
Why?
|
Statistics as Topic | 2 | 2014 | 2373 | 0.140 |
Why?
|
Health Surveys | 3 | 2016 | 4037 | 0.140 |
Why?
|
Professional Autonomy | 2 | 2008 | 177 | 0.140 |
Why?
|
Diffusion of Innovation | 1 | 2001 | 725 | 0.140 |
Why?
|
Temperature | 1 | 2022 | 2206 | 0.130 |
Why?
|
Ethics | 1 | 1995 | 94 | 0.130 |
Why?
|
Health Transition | 1 | 2015 | 34 | 0.130 |
Why?
|
Diphosphonates | 1 | 2000 | 623 | 0.130 |
Why?
|
Canada | 4 | 2015 | 2065 | 0.130 |
Why?
|
Seroepidemiologic Studies | 1 | 2016 | 401 | 0.130 |
Why?
|
Emergency Medical Services | 2 | 2013 | 1917 | 0.130 |
Why?
|
Clinical Protocols | 2 | 2017 | 1462 | 0.130 |
Why?
|
Severity of Illness Index | 3 | 2022 | 15540 | 0.120 |
Why?
|
Reproductive Health Services | 1 | 2015 | 80 | 0.120 |
Why?
|
Research Report | 1 | 2017 | 355 | 0.120 |
Why?
|
Prognosis | 7 | 2011 | 29063 | 0.120 |
Why?
|
Trachoma | 1 | 2013 | 29 | 0.120 |
Why?
|
Rural Health | 2 | 2016 | 305 | 0.120 |
Why?
|
Elephantiasis, Filarial | 1 | 2013 | 29 | 0.110 |
Why?
|
Onchocerciasis | 1 | 2013 | 24 | 0.110 |
Why?
|
Hospital Departments | 1 | 1993 | 137 | 0.110 |
Why?
|
Insurance Coverage | 1 | 2005 | 1901 | 0.110 |
Why?
|
Personal Autonomy | 2 | 2005 | 298 | 0.110 |
Why?
|
Tuberculosis | 3 | 2014 | 1912 | 0.110 |
Why?
|
Cost Control | 3 | 2003 | 624 | 0.110 |
Why?
|
Calcium Channel Blockers | 1 | 2016 | 690 | 0.110 |
Why?
|
Helminthiasis | 1 | 2013 | 66 | 0.110 |
Why?
|
Attitude to Health | 1 | 2002 | 2052 | 0.110 |
Why?
|
Internationality | 3 | 2014 | 1003 | 0.110 |
Why?
|
Leishmaniasis, Visceral | 1 | 2013 | 94 | 0.110 |
Why?
|
Leukemia | 2 | 2008 | 1511 | 0.110 |
Why?
|
Anti-Infective Agents | 1 | 2020 | 972 | 0.100 |
Why?
|
Conservation of Natural Resources | 1 | 2014 | 204 | 0.100 |
Why?
|
Health Services Research | 3 | 2004 | 1836 | 0.100 |
Why?
|
Bone Marrow Transplantation | 1 | 2000 | 2765 | 0.100 |
Why?
|
Pregnancy Complications | 2 | 2013 | 2861 | 0.100 |
Why?
|
Birth Weight | 3 | 2022 | 2069 | 0.100 |
Why?
|
Mathematical Computing | 1 | 2011 | 147 | 0.100 |
Why?
|
Emphysema | 1 | 2014 | 247 | 0.100 |
Why?
|
Chronic Disease | 2 | 2017 | 9146 | 0.100 |
Why?
|
Policy | 1 | 2015 | 508 | 0.100 |
Why?
|
Risk Factors | 10 | 2021 | 72290 | 0.100 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2020 | 1519 | 0.100 |
Why?
|
Meta-Analysis as Topic | 1 | 2016 | 1344 | 0.100 |
Why?
|
Reference Standards | 1 | 2015 | 1025 | 0.100 |
Why?
|
Mothers | 1 | 2021 | 2165 | 0.100 |
Why?
|
Accidents, Traffic | 1 | 2016 | 819 | 0.100 |
Why?
|
Needs Assessment | 2 | 2015 | 1147 | 0.100 |
Why?
|
Diabetic Angiopathies | 1 | 2016 | 818 | 0.100 |
Why?
|
Checklist | 1 | 2018 | 833 | 0.090 |
Why?
|
Ambulatory Care | 1 | 2021 | 2708 | 0.090 |
Why?
|
Infant, Very Low Birth Weight | 2 | 2017 | 406 | 0.090 |
Why?
|
Drugs, Generic | 2 | 2012 | 421 | 0.090 |
Why?
|
Middle East | 2 | 2022 | 219 | 0.090 |
Why?
|
Dengue | 1 | 2013 | 256 | 0.090 |
Why?
|
Urban Health Services | 2 | 2016 | 179 | 0.090 |
Why?
|
Chemoprevention | 1 | 2012 | 319 | 0.090 |
Why?
|
Bone Density | 2 | 2000 | 3468 | 0.090 |
Why?
|
Diarrhea | 1 | 2016 | 1348 | 0.090 |
Why?
|
Risk Reduction Behavior | 1 | 2016 | 1125 | 0.090 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2016 | 1518 | 0.090 |
Why?
|
Research Design | 4 | 2017 | 5987 | 0.080 |
Why?
|
Judgment | 1 | 2011 | 281 | 0.080 |
Why?
|
Research | 1 | 1998 | 1999 | 0.080 |
Why?
|
Respiratory Tract Infections | 1 | 2016 | 961 | 0.080 |
Why?
|
Infant, Extremely Low Birth Weight | 1 | 2009 | 89 | 0.080 |
Why?
|
Treatment Outcome | 10 | 2018 | 63114 | 0.080 |
Why?
|
Pneumonia | 1 | 2021 | 2133 | 0.080 |
Why?
|
Endocarditis, Bacterial | 1 | 2013 | 455 | 0.080 |
Why?
|
Ethics Committees | 1 | 2008 | 54 | 0.080 |
Why?
|
Metabolic Diseases | 1 | 2015 | 658 | 0.080 |
Why?
|
Decision Support Systems, Clinical | 1 | 2018 | 1164 | 0.080 |
Why?
|
Efficiency, Organizational | 1 | 2013 | 695 | 0.080 |
Why?
|
Child Welfare | 1 | 2012 | 523 | 0.080 |
Why?
|
Politics | 4 | 2005 | 791 | 0.080 |
Why?
|
Brain Damage, Chronic | 1 | 2008 | 265 | 0.080 |
Why?
|
Registries | 3 | 2018 | 8089 | 0.080 |
Why?
|
Dissent and Disputes | 1 | 2008 | 141 | 0.080 |
Why?
|
Quality Indicators, Health Care | 1 | 2018 | 1831 | 0.070 |
Why?
|
Administrative Personnel | 1 | 2008 | 187 | 0.070 |
Why?
|
Pneumococcal Vaccines | 1 | 2011 | 391 | 0.070 |
Why?
|
Fractures, Bone | 1 | 1999 | 1947 | 0.070 |
Why?
|
Rural Health Services | 2 | 2016 | 379 | 0.070 |
Why?
|
Occupational Diseases | 1 | 2015 | 1471 | 0.070 |
Why?
|
Evidence-Based Practice | 1 | 2011 | 500 | 0.070 |
Why?
|
Intensive Care Units | 2 | 2017 | 3679 | 0.070 |
Why?
|
Vaccination | 2 | 2021 | 3278 | 0.070 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 2007 | 245 | 0.070 |
Why?
|
Fertilization in Vitro | 1 | 1994 | 1284 | 0.070 |
Why?
|
Mexico | 1 | 2008 | 690 | 0.070 |
Why?
|
Trisomy | 1 | 2007 | 266 | 0.070 |
Why?
|
Life Style | 3 | 2008 | 3835 | 0.070 |
Why?
|
Aged, 80 and over | 4 | 2020 | 57776 | 0.070 |
Why?
|
Intensive Care, Neonatal | 1 | 2007 | 198 | 0.070 |
Why?
|
Patient Preference | 1 | 2012 | 890 | 0.060 |
Why?
|
Bariatric Surgery | 1 | 2015 | 952 | 0.060 |
Why?
|
Liver Transplantation | 1 | 1996 | 2119 | 0.060 |
Why?
|
Epilepsy | 1 | 2020 | 3310 | 0.060 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2020 | 3523 | 0.060 |
Why?
|
Multiple Organ Failure | 1 | 2007 | 390 | 0.060 |
Why?
|
Hospitals, Teaching | 1 | 2009 | 1179 | 0.060 |
Why?
|
Educational Status | 2 | 2012 | 2540 | 0.060 |
Why?
|
Aspirin | 1 | 2016 | 3282 | 0.060 |
Why?
|
Trust | 1 | 2008 | 505 | 0.060 |
Why?
|
Obesity, Morbid | 1 | 2015 | 1213 | 0.060 |
Why?
|
Depressive Disorder, Major | 1 | 2021 | 4644 | 0.060 |
Why?
|
Risk Assessment | 4 | 2017 | 23338 | 0.060 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2016 | 3068 | 0.060 |
Why?
|
Primary Health Care | 2 | 2016 | 4558 | 0.060 |
Why?
|
Taxes | 1 | 2005 | 221 | 0.060 |
Why?
|
Aortic Valve | 1 | 2013 | 1922 | 0.060 |
Why?
|
Africa, Northern | 1 | 2022 | 82 | 0.050 |
Why?
|
Wounds and Injuries | 1 | 2015 | 2400 | 0.050 |
Why?
|
Drug Prescriptions | 1 | 2012 | 1637 | 0.050 |
Why?
|
Decision Making, Organizational | 1 | 2003 | 139 | 0.050 |
Why?
|
Quality Improvement | 1 | 2018 | 3749 | 0.050 |
Why?
|
Community Health Planning | 1 | 2003 | 165 | 0.050 |
Why?
|
United States | 7 | 2020 | 69872 | 0.050 |
Why?
|
Organizational Objectives | 2 | 2014 | 438 | 0.050 |
Why?
|
Time Factors | 4 | 2017 | 40075 | 0.050 |
Why?
|
Professional-Family Relations | 1 | 2006 | 482 | 0.050 |
Why?
|
Schizophrenia | 1 | 2020 | 6882 | 0.050 |
Why?
|
Heart Diseases | 1 | 2014 | 2788 | 0.050 |
Why?
|
Electronic Health Records | 1 | 2018 | 4468 | 0.050 |
Why?
|
Patient Advocacy | 2 | 2001 | 353 | 0.050 |
Why?
|
Environmental Exposure | 1 | 2015 | 4234 | 0.050 |
Why?
|
Data Interpretation, Statistical | 1 | 2011 | 2716 | 0.050 |
Why?
|
Government Programs | 1 | 2023 | 275 | 0.050 |
Why?
|
Stroke | 2 | 2014 | 9981 | 0.050 |
Why?
|
Drug Combinations | 2 | 2016 | 1959 | 0.040 |
Why?
|
Risk-Taking | 1 | 2005 | 986 | 0.040 |
Why?
|
Transportation | 1 | 2021 | 214 | 0.040 |
Why?
|
Abnormalities, Multiple | 1 | 2007 | 1416 | 0.040 |
Why?
|
Prevalence | 1 | 2016 | 15226 | 0.040 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2007 | 980 | 0.040 |
Why?
|
Sex Factors | 2 | 2012 | 10397 | 0.040 |
Why?
|
Age Distribution | 2 | 2014 | 2902 | 0.040 |
Why?
|
Germany | 1 | 2000 | 862 | 0.040 |
Why?
|
Denmark | 1 | 2000 | 738 | 0.040 |
Why?
|
Ethical Theory | 1 | 2017 | 34 | 0.040 |
Why?
|
Hospitals, Public | 1 | 2019 | 207 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2021 | 11725 | 0.040 |
Why?
|
Online Systems | 1 | 2017 | 184 | 0.040 |
Why?
|
Patient Care Planning | 1 | 2002 | 921 | 0.030 |
Why?
|
Ethics, Research | 1 | 2017 | 191 | 0.030 |
Why?
|
Longevity | 1 | 2003 | 1070 | 0.030 |
Why?
|
House Calls | 1 | 2017 | 160 | 0.030 |
Why?
|
Netherlands | 1 | 2000 | 2170 | 0.030 |
Why?
|
Pensions | 1 | 2015 | 15 | 0.030 |
Why?
|
Sanitation | 1 | 2015 | 93 | 0.030 |
Why?
|
Workplace | 1 | 2021 | 836 | 0.030 |
Why?
|
Culture | 1 | 2019 | 633 | 0.030 |
Why?
|
Smoking | 2 | 2017 | 8987 | 0.030 |
Why?
|
Government | 1 | 1995 | 165 | 0.030 |
Why?
|
Empirical Research | 1 | 2014 | 120 | 0.030 |
Why?
|
Consultants | 1 | 2014 | 53 | 0.030 |
Why?
|
Government Regulation | 2 | 1995 | 522 | 0.030 |
Why?
|
Housing | 1 | 2019 | 664 | 0.030 |
Why?
|
Financing, Organized | 1 | 1995 | 202 | 0.030 |
Why?
|
Hospitals, District | 1 | 2014 | 106 | 0.030 |
Why?
|
Public Policy | 1 | 2018 | 572 | 0.030 |
Why?
|
Aging | 1 | 2012 | 8664 | 0.030 |
Why?
|
Health Behavior | 2 | 2015 | 2636 | 0.030 |
Why?
|
Urban Health | 1 | 2016 | 547 | 0.030 |
Why?
|
Markov Chains | 1 | 2016 | 969 | 0.030 |
Why?
|
State Health Plans | 1 | 1994 | 216 | 0.030 |
Why?
|
Parents | 1 | 2006 | 3407 | 0.030 |
Why?
|
Genomics | 1 | 2008 | 5720 | 0.030 |
Why?
|
Transplantation, Homologous | 1 | 2000 | 4776 | 0.030 |
Why?
|
Critical Care | 1 | 2004 | 2647 | 0.030 |
Why?
|
Antibodies, Monoclonal | 1 | 2009 | 9274 | 0.030 |
Why?
|
Head | 1 | 2017 | 880 | 0.030 |
Why?
|
Expert Testimony | 1 | 2014 | 356 | 0.020 |
Why?
|
Myocardial Infarction | 1 | 2012 | 11727 | 0.020 |
Why?
|
Body Height | 1 | 2017 | 1577 | 0.020 |
Why?
|
Emergency Treatment | 1 | 2013 | 517 | 0.020 |
Why?
|
Morbidity | 1 | 2015 | 1769 | 0.020 |
Why?
|
Europe | 1 | 1996 | 3339 | 0.020 |
Why?
|
Sex Distribution | 1 | 2014 | 2297 | 0.020 |
Why?
|
Safety | 1 | 2014 | 1186 | 0.020 |
Why?
|
Perception | 1 | 2015 | 1198 | 0.020 |
Why?
|
Breast Feeding | 1 | 2017 | 1338 | 0.020 |
Why?
|
Consensus | 1 | 2017 | 2959 | 0.020 |
Why?
|
Africa South of the Sahara | 1 | 2011 | 724 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2015 | 2453 | 0.020 |
Why?
|
Ovarian Neoplasms | 1 | 2005 | 4838 | 0.020 |
Why?
|
Interprofessional Relations | 1 | 2014 | 1011 | 0.020 |
Why?
|
Colorectal Neoplasms | 1 | 2007 | 6773 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2014 | 2715 | 0.020 |
Why?
|
Nutritional Status | 1 | 2015 | 1609 | 0.020 |
Why?
|
Weight Gain | 1 | 2017 | 2292 | 0.020 |
Why?
|
Risk | 1 | 2019 | 9687 | 0.020 |
Why?
|
Social Class | 1 | 2015 | 1999 | 0.020 |
Why?
|
Internal Medicine | 1 | 1993 | 1009 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2008 | 17446 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2000 | 12026 | 0.020 |
Why?
|
Residence Characteristics | 1 | 2016 | 2050 | 0.020 |
Why?
|
Ontario | 1 | 2006 | 383 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2014 | 6365 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 6489 | 0.020 |
Why?
|
Child Development | 1 | 2017 | 2223 | 0.020 |
Why?
|
Occupational Exposure | 1 | 2015 | 1796 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2014 | 5078 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2018 | 77449 | 0.010 |
Why?
|
Cause of Death | 1 | 2014 | 3584 | 0.010 |
Why?
|
Planning Techniques | 1 | 2003 | 82 | 0.010 |
Why?
|
Local Government | 1 | 2003 | 80 | 0.010 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2014 | 2026 | 0.010 |
Why?
|
Patient Acceptance of Health Care | 1 | 2016 | 3022 | 0.010 |
Why?
|
Anticholesteremic Agents | 1 | 2009 | 979 | 0.010 |
Why?
|
Databases, Factual | 1 | 2015 | 7729 | 0.010 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2005 | 1770 | 0.010 |
Why?
|
Survival Analysis | 1 | 2012 | 10252 | 0.010 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2005 | 3479 | 0.010 |
Why?
|
Blood Pressure | 1 | 2012 | 8554 | 0.010 |
Why?
|
Cohort Studies | 1 | 2018 | 40561 | 0.010 |
Why?
|
Oregon | 1 | 1994 | 140 | 0.010 |
Why?
|
Hospitals, Private | 1 | 1994 | 63 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2008 | 3923 | 0.010 |
Why?
|
Individuality | 1 | 1994 | 307 | 0.010 |
Why?
|
Prospective Studies | 1 | 2015 | 53288 | 0.010 |
Why?
|
Vulnerable Populations | 1 | 1994 | 687 | 0.010 |
Why?
|